PRODUCTS
| Category | Others |
|---|---|
| Sub. Category | Kidney Disease |
| Ingredient | Each tablet contains Tolvaptan 15mg, 30mg |
| Indication | Clinically significant hypervolemic or euvolemic hyponatremia in patients with heart failure, syndrome of abnormal antidiuretic hormone secretion (SIADH), etc |
|---|---|
| Element | Each tablet contains Tolvaptan 15mg, 30mg |
| Effect | |
| Use | The recommended initial dose for adults is 15 mg once daily. To reach the target serum sodium concentration, increase the dose to 30 mg once a day at
an interval of at least 24 hours, and increase to a maximum of 60 mg once a day. To minimize the risk of liver damage, do not administer for more than 30 days. |
| Package |
